Healthy Population — The Role of Beta Oscillation in Mental Time Travel
Citation(s)
Anelli F, Avanzi S, Arzy S, Mancuso M, Frassinetti F Effects of spatial attention on mental time travel in patients with neglect. Cortex. 2018 Apr;101:192-205. doi: 10.1016/j.cortex.2018.01.012. Epub 2018 Feb 2.
Arzy S, Collette S, Ionta S, Fornari E, Blanke O Subjective mental time: the functional architecture of projecting the self to past and future. Eur J Neurosci. 2009 Nov;30(10):2009-17. doi: 10.1111/j.1460-9568.2009.06974.x. Epub 2009 Nov 11.
D'Angelo M, Frassinetti F, Cappelletti M The Role of Beta Oscillations in Mental Time Travel. Psychol Sci. 2023 Apr;34(4):490-500. doi: 10.1177/09567976221147259. Epub 2023 Feb 16.
Lenggenhager B, Halje P, Blanke O Alpha band oscillations correlate with illusory self-location induced by virtual reality. Eur J Neurosci. 2011 May;33(10):1935-43. doi: 10.1111/j.1460-9568.2011.07647.x. Epub 2011 Mar 13.
Wiener M, Parikh A, Krakow A, Coslett HB An Intrinsic Role of Beta Oscillations in Memory for Time Estimation. Sci Rep. 2018 May 22;8(1):7992. doi: 10.1038/s41598-018-26385-6.
The Role of Beta Oscillation in Mental Time Travel: a tACS Study in Healthy Subjects
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
